The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Direct Gene Transfer into Skeletal Muscle In Vivo : Factors Affecting Efficiency of Transfer and Stability of Expression
Abstract
Striated muscle is the only tissue found to be capable of taking up and expressing reporter genes that are transferred in the form of plasmid DNA. Thus, direct gene transfer is a potential method of gene therapy for the primary inherited myopathies. However, results to date have had insufficient and too variable expression to consider using direct gene transfer in human trials. We have determined that much of the variability of expression is due to nonuniform distribution of substances injected into skeletal muscle in vivo, and have developed a model to ameliorate this. Preinjection of muscles with a relatively large volume of hypertonic sucrose improves the distribution of injected substances and results in significantly less variable expression of reporter genes for luciferase or β-galactosidase; the coefficient of variation for mean luciferase activity was reduced from about 120% to 25%. Expression is not directly proportional to dose, but is more so if the muscles are preinjected with sucrose than not. Expression is higher and less variable if DNA is injected in a larger than a smaller volume. The choice of promoter appears to be particularly important. Luciferase reporter gene expression from the SV40 promoter was transient and low, whereas expression driven by the Rous sarcoma virus (RSV) promoter was high and sustained, such that a 1,000-fold difference in expression could be observed. The mechanism of gene uptake is still unknown, but our findings indicate that fibers damaged by the injection procedure do not take up and express plasmid DNA. The technique of direct gene transfer into muscle by intramuscular injection of plasmid DNA has been improved by introducing a preinjection procedure. Although the levels of expression are still insufficient to consider human trials of gene therapy for treatment of inherited primary myopathies, this method offers an excellent animal model to evaluate physiological regulation of gene expression in muscle. In addition, direct gene transfer may provide a simple and safe method to deliver recombinant proteins to the circulation in order to treat other (i.e., nonmuscle) inherited disorders.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Direct Gene Transfer into Mouse Muscle in Vivo
Wolff, J. A., Malone, R. W., Williams, P., Chong, W., Acsadi, G., Jani, A., & Felgner, P. L. (1990) · Science · doi:10.1126/science.1690918 · Cited by 4,173 · cited 3×
“intra The possibility of muscle gene therapy was encouraged by the finding by Wolff et al. (1990) that it is possible transfer genes into skeletal muscle in vivo by direct injection plasmid DNA.”
Firefly luciferase gene: structure and expression in mammalian cells.
de Wet, J. R., Wood, K. V., DeLuca, M., Helinski, D. R., & Subramani, S. (1987) · Molecular and Cellular Biology · doi:10.1128/mcb.7.2.725 · Cited by 3,087
Gorman, C. M., Merlino, G. T., Willingham, M. C., Pastan, I., & Howard, B. H. (1982) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.79.22.6777 · Cited by 1,298
Use of a recombinant retrovirus to study post-implantation cell lineage in mouse embryos.
Sanes, J. R., Rubenstein, J. L., & Nicolas, J. F. (1986) · The EMBO Journal · doi:10.1002/j.1460-2075.1986.tb04620.x · Cited by 1,105
Human gene therapy comes of age
Miller, A. D. (1992) · Nature · doi:10.1038/357455a0 · Cited by 908
Two distinct enhancers with different cell specificities coexist in the regulatory region of polyoma
Herbomel, P., Bourachot, B., & Yaniv, M. (1984) · Cell · doi:10.1016/0092-8674(84)90472-0 · Cited by 837
Long-term persistence of plasmid DNA and foreign gone expression in mouse muscle
Wolff, J. A., Ludtke, J. J., Acsadi, G., Williams, P., & Jani, A. (1992) · Human Molecular Genetics · doi:10.1093/hmg/1.6.363 · Cited by 738
Widespread long-term gene transfer to mouse skeletal muscles and heart.
Stratford-Perricaudet, L. D., Makeh, I., Perricaudet, M., & Briand, P. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115902 · Cited by 580
Methods for Studying Mononuclear Phagocytes
(1981) · Elsevier eBooks · doi:10.1016/b978-0-12-044220-1.x5001-6 · Cited by 571
Systemic Delivery of Human Growth Hormone by Injection of Genetically Engineered Myoblasts
Dhawan, J., Pan, L. C., Pavlath, G. K., Travis, M. A., Lanctot, A. M., & Blau, H. M. (1991) · Science · doi:10.1126/science.1962213 · Cited by 317
Cited by
Baumgartner, I., Pieczek, A., Manor, O., Blair, R., Kearney, M., Walsh, K., & Isner, J. M. (1998) · Circulation · doi:10.1161/01.cir.97.12.1114 · Cited by 1,098
Gene transfer into muscle by electroporation in vivo
Aihara, H., & Miyazaki, J.-I. (1998) · Nature Biotechnology · doi:10.1038/nbt0998-867 · Cited by 944
Gene Therapy for Cancer: What Have We Done and Where Are We Going?
Roth, J. A., & Cristiano, R. J. (1997) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/89.1.21 · Cited by 635
Kessler, P. D., Podsakoff, G. M., Chen, X., McQuiston, S. A., Colosi, P. C., Matelis, L. A., Kurtzman, G. J., & Byrne, B. J. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.24.14082 · Cited by 614
Nonviral Vectors in the New Millennium: Delivery Barriers in Gene Transfer
Nishikawa, M., & Huang, L. (2001) · Human Gene Therapy · doi:10.1089/104303401750195836 · Cited by 574
Raz, E., Carson, D. A., Parker, S. E., Parr, T. B., Abai, A. M., Aichinger, G., Gromkowski, S. H., Singh, M., Lew, D., & Yankauckas, M. A. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.20.9519 · Cited by 543
Abdallah, B., Hassan, A., Benoist, C., Goula, D., Behr, J. P., & Demeneix, B. A. (1996) · Human Gene Therapy · doi:10.1089/hum.1996.7.16-1947 · Cited by 541
Self-citationXiang, Z., & Ertl, H. C. J. (1995) · Immunity · doi:10.1016/s1074-7613(95)80001-8 · Cited by 477
Key issues in non-viral gene delivery
Pouton, C. W., & Seymour, L. W. (1998) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(98)00048-9 · Cited by 440
DNA and RNA-based vaccines: principles, progress and prospects
Leitner, W. W., Ying, H., & Restifo, N. P. (1999) · Vaccine · doi:10.1016/s0264-410x(99)00271-6 · Cited by 402
Sequence motifs in adenoviral DNA block immune activation by stimulatory CpG motifs
Krieg, A. M., Wu, T., Weeratna, R., Efler, S. M., Love-Homan, L., Yang, L., Yi, A.-K., Short, D., & Davis, H. L. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.21.12631 · Cited by 397
Self-citationTsurumi, Y., Takeshita, S., Chen, D., Kearney, M., Rossow, S. T., Passeri, J., Horowitz, J. R., Symes, J. F., & Isner, J. M. (1996) · Circulation · doi:10.1161/01.cir.94.12.3281 · Cited by 389
Doe, B., Selby, M., Barnett, S., Baenziger, J., & Walker, C. M. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.16.8578 · Cited by 340
Distribution of DNA Vaccines Determines Their Immunogenicity After Intramuscular Injection in Mice
Dupuis, M., Denis-Mize, K., Woo, C., Goldbeck, C., Selby, M. J., Chen, M., Otten, G. R., Ulmer, J. B., Donnelly, J. J., Ott, G., et al. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.5.2850 · Cited by 327
Plasmid DNA Is Superior to Viral Vectors for Direct Gene Transfer into Adult Mouse Skeletal Muscle
Davis, H. L., Demeneix, B. A., Quantin, B., Coulombe, J., & Whalen, R. G. (1993) · Human Gene Therapy · doi:10.1089/hum.1993.4.6-733 · Cited by 307
Self-citationSatkauskas, S., Bureau, M. F., Puc, M., Mahfoudi, A., Scherman, D., Miklavcic, D., & Mir, L. M. (2002) · Molecular Therapy · doi:10.1006/mthe.2002.0526 · Cited by 306
Pouton, C. W., & Seymour, L. W. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00133-2 · Cited by 291
Activation of an alternative NF‐ΚB pathway in skeletal muscle during disuse atrophy
Hunter, R. B., Stevenson, E. J., Koncarevic, A., Mitchell-Felton, H., Essig, D. A., & Kandarian, S. C. (2002) · The FASEB Journal · doi:10.1096/fj.01-0866com · Cited by 281
ULMER, J. B., DECK, R. R., DEWITT, C. M., DONNELLY, J. J., & LIU, M. A. (1996) · Immunology · doi:10.1046/j.1365-2567.1996.d01-718.x · Cited by 259
Metadata
- Authors
- Davis, H. L., Whalen, R. G., & Demeneix, B. A.
- Venue
- Human Gene Therapy
- Publisher
- SAGE Publications
- Published
- 1993-04
- Volume
- 4
- Issue
- 2
- Pages
- 151-159
- ISSN
- 1043-0342 (ISSN-L)
- 1557-7422
- OpenAlex
- W2050138695
- Cited by
- 371
- References
- 32
- FWCI
- 9.49
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.